New and emerging trends in the treatment of atopic dermatitis

Patient Preference and Adherence

Volumn 2, Issue , 2009, Pages 387-392

  Gelbard, Christina M ^a   Hebert, Adelaide A ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Atopic dermatitis; Calcineurin inhibitors; Cyclosporine; IFN ; Methotrexate; Mycophenolate mofetil; Topical corticosteroids

Indexed keywords

EID: 80054892646     PISSN: None     EISSN: 1177889X     Source Type: Journal    
DOI: 10.2147/PPA.S3345     Document Type: Review

References (22)

1. Berth-Jones J, Takwale A, Tan E, et al. 2002. Azathioprine in severe adult atopic dermatitis: a double-blind, placebo-controlled, crossover trial. Br J Dermatol, 147:324-30.
2. Eichenfield LF, Basu S, Calvarese B, et al. 2007. Effect of desonide hydrogel 0.05% on the hypothalamic-pituitary-adrenal axis in pediatric subjects with moderate to severe atopic dermatitis. Pediatr Dermatol, 24:289-95.
3. Goujon C., Berard F, Dahel K, et al. 2006. Methotrexate for the treatment of adult atopic dermatitis. Eur J Dermatol, 16:155-8.
4. Harper J. I, Ahmed I, Barclay G, et al. 2000. Cyclosporin for severe childhood atopic dermatitis: short course versus continuous therapy. Br J Dermatol, 142:52-8.
5. Heller M., Shin HT, Orlow SJ, et al. 2007. Mycophenolate mofetil for severe childhood atopic dermatitis: experience in 14 patients. Br J Dermatol, 157:127-32.
6. Hijnen D. J, Ten Berge O, Timmer-De Mik L, et al. 2007. Efficacy and safety of long-term treatment with cyclosporin A for atopic dermatitis. J Eur Acad Dermatol Venereol, 2185-9.
7. Jang I. G, Yang JK, Lee HJ, et al. 2000. Clinical improvement and immunohistochemical findings in severe atopic dermatitis treated with interferon gamma. J Am Acad Dermatol, 42:1033-40.
8. Lebwohl M., Gower T. 2006. A safety assessment of topical calcineurin inhibitors in the treatment of atopic dermatitis. Med Gen Med, 8:8.
9. Lee, SS, Tan, AW, Giam, YC. 2004. Cyclosporin in the treatment of severe atopic dermatitis: a retrospective study. Ann Acad Med Singapore, 33:311-3.
10. Lipozencic J., Wolf R. 2007. Atopic dermatitis: an update and review of the literature. Dermatol Clin, 25:05-12, x.
11. Meagher L. J, Wines NY, Cooper AJ. 2002. Atopic dermatitis: review of immunopathogenesis and advances in immunosuppressive therapy. Australas J Dermatol, 43:47-54.
12. Meggitt S. J, Gray JC, Reynolds NJ. 2006. Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomised controlled trial. Lancet, 367:39-46.
13. Meggitt S. J, Reynolds NJ. 2001. Azathioprine for atopic dermatitis. Clin Exp Dermatol, 26:69-75.
14. Munzenberger P. J, Montejo JM. 2007. Safety of topical calcineurin inhibitors for the treatment of atopic dermatitis. Pharmacotherapy, 27:020-8.
15. Murray M. L, Cohen JB. 2007. Mycophenolate mofetil therapy for moderate to severe atopic dermatitis. Clin Exp Dermatol, 32:3-7.
16. Paller A. S, Lebwohl M, Fleischer AB Jr, et al. 2005. Tacrolimus ointment is more effective than pimecrolimus cream with a similar safety profile in the treatment of atopic dermatitis: results from 3 randomized, comparative studies. J Am Acad Dermatol, 52:810-22.
17. Reitamo S., Rustin M, Ruzicka T, et al. 2002a. Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone butyrate ointment in adult patients with atopic dermatitis. J Allergy Clin Immunol, 109:547-55.
18. Reitamo S., van Leent EJ, Ho V, et al. 2002b. Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone acetate ointment in children with atopic dermatitis. J Allergy Clin Immunol, 109:539-46.
19. Schmitt J., Schmitt N, Meurer M. 2007. Cyclosporin in the treatment of patients with atopic eczema-a systematic review and meta-analysis. J Eur Acad Dermatol Venereol, 21:606-19.
20. Stahn C., Lowenberg M, Hommes DW, et al. 2007. Molecular mechanisms of glucocorticoid action and selective glucocorticoid receptor agonists. Mol Cell Endocrinol, 275:71-8.
21. Weatherhead S. C, Wahie S, Reynolds NJ, et al. 2007. An open-label, dose-ranging study of methotrexate for moderate-to-severe adult atopic eczema. Br J Dermatol, 156:346-51.
22. Wolverton S. 2007. Comprehensive dermatologic drug therapy. 2nd ed. Philadelphia: Elsevier.